University of Oslo
Oslo, Norway
NCT Number: NCT01023763
The primary objective for the project is to evaluate whether nursing home residents who require intravenous fluids and intravenous antibiotics, can be treated just as well or even better in the nursing home as in the hospital. In Vestfold, Norway, a structured training program in the intravenous treatment of dehydration and infections in nursing homes is planned. The 3IV study will evaluate if this leads to an equal or better patient trajectory and reduced hospital admittance.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
Oslo, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A structured training program in nursing homes in the intravenous treatment of dehydration and infections.
Time frame: Within 30 days after disease onset
Time frame: Primarily within 30 days after disease onset
Time frame: Primarily within 30 days after disease onset
Time frame: Primarily within 30 days after disease onset
University of Oslo
Other
Can a Structured Training Program in Intravenous Treatment of Infections in Nursing Homes Lead to a Better Patient Trajectory and Reduced Hospital Admittance?
Acronym: 3IV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02505386
Infections
Bordeaux, France
View Trial DetailsNCT05978037
Infections, Malaria
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT02231879
Agammaglobulinemia, Agranulocytosis
Bethesda, Maryland, United States
View Trial DetailsNCT05180110
Infections, Inflammation
Edinburgh, United Kingdom
View Trial Details